Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Types of Expression Host Systems
- Mechanism of Action of Recombinant Proteins
- Agonists
- Antagonists
- Common Steps Involved in Recombinant Protein Production
Chapter 3 Market Dynamics
- Drivers
- Growing R&D Investments in Biopharmaceuticals
- Increasing Demand for Non-Hybridoma Techniques
- Restraints
- High Production Costs
- Post-Translational Modifications and Protein Stability
- Opportunities
- Diagnostic and Therapeutic Applications of Recombinant Antibodies
- Continuous Manufacturing and Improving Product Yields
Chapter 4 Emerging Technologies and Developments
- Overview
- Emerging Technologies
- Protein-Engineering Advances
- CRISPR Genome Editing
- Cell-Free Protein Synthesis
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Recombinant Proteins, by Product Type
- Hormones
- Market Size and Forecast
- Cytokines
- Market Size and Forecast
- Enzymes
- Market Size and Forecast
- Antibodies
- Market Size and Forecast
- Antigens
- Market Size and Forecast
- Others
- Market Size and Forecast
- Global Market for Recombinant Proteins, by Host Cell Type
- Bacterial Host Cells
- Market Size and Forecast
- Yeast and Fungi Cells
- Market Size and Forecast
- Mammalian Cells
- Market Size and Forecast
- Insect Cells
- Market Size and Forecast
- Other Cells
- Market Size and Forecast
- Global Market for Recombinant Proteins, by Application
- Therapeutics and Vaccines
- Market Size and Forecast
- Biomedical Research
- Market Size and Forecast
- Diagnostics
- Market Size and Forecast
- Geographic Breakdown
- Global Market for Recombinant Proteins, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Competitive Landscape
- M&A Analysis
- Clinical Trial Activities
Chapter 7 ESG Perspective in the Recombinant Proteins Market
- Sustainability in the Recombinant Proteins Market
- Understanding the ESG Data
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
List of Tables
Summary Table: Global Market for Recombinant Proteins, by Region, Through 2029
Table 1: Comparison of Different Protein Expression Host Systems
Table 2: R&D Expenditures of Key Biopharmaceutical Companies, 2023
Table 3: Global Market for Recombinant Proteins, by Product Type, Through 2029
Table 4: Global Market for Recombinant Hormone Proteins, by Region, Through 2029
Table 5: Global Market for Recombinant Cytokine Proteins, by Region, Through 2029
Table 6: Global Market for Recombinant Enzyme Proteins, by Region, Through 2029
Table 7: Global Market for Recombinant Antibody Proteins, by Region, Through 2029
Table 8: Global Market for Recombinant Antigen Proteins, by Region, Through 2029
Table 9: Global Patient Population Diagnosed with Bleeding Disorders
Table 10: Global Market for Other Recombinant Proteins, by Region, Through 2029
Table 11: Global Market for Recombinant Proteins, by Host Cell Type, Through 2029
Table 12: Global Market for Recombinant Proteins from Bacterial Host Cells, by Region, Through 2029
Table 13: Global Market for Recombinant Proteins from Yeast and Fungi Host Cells, by Region, Through 2029
Table 14: Global Market for Recombinant Proteins from Mammalian Host Cells, by Region, Through 2029
Table 15: Global Market for Recombinant Proteins from Insect Host Cells, by Region, Through 2029
Table 16: Global Market for Recombinant Proteins from Other Host Cells, by Region, Through 2029
Table 17: Global Market for Recombinant Proteins, by Application, Through 2029
Table 18: Therapeutic Applications of Recombinant Proteins, by Product Type
Table 19: Global Market for Recombinant Proteins for Therapeutic and Vaccine Applications, by Region, Through 2029
Table 20: Global Market for Recombinant Proteins for Biomedical Research, by Region, Through 2029
Table 21: Global Market for Recombinant Proteins for Diagnostics, by Region, Through 2029
Table 22: Global Market for Recombinant Proteins, by Region, Through 2029
Table 23: North American Market for Recombinant Proteins, by Product Type, Through 2029
Table 24: North American Market for Recombinant Proteins, by Host Cell Type, Through 2029
Table 25: North American Market for Recombinant Proteins, by Application, Through 2029
Table 26: North American Market for Recombinant Proteins, by Country, Through 2029
Table 27: European Market for Recombinant Proteins, by Product Type, Through 2029
Table 28: European Market for Recombinant Proteins, by Host Cell Type, Through 2029
Table 29: European Market for Recombinant Proteins, by Application, Through 2029
Table 30: European Market for Recombinant Proteins, by Country, Through 2029
Table 31: Asia-Pacific Market for Recombinant Proteins, by Product Type, Through 2029
Table 32: Asia-Pacific Market for Recombinant Proteins, by Host Cell Type, Through 2029
Table 33: Asia-Pacific Market for Recombinant Proteins, by Application, Through 2029
Table 34: Asia-Pacific Market for Recombinant Proteins, by Country, Through 2029
Table 35: RoW Market for Recombinant Proteins, by Product Type, Through 2029
Table 36: RoW Market for Recombinant Proteins, by Host Cell Type, Through 2029
Table 37: RoW Market for Recombinant Proteins, by Application, Through 2029
Table 38: Top Recombinant Protein Drug Developers, 2023
Table 39: Major Strategic Alliances in the Recombinant Proteins Industry, 2022-2024
Table 40: Technology Driven Partnerships and Acquisitions in the Recombinant Protein Industry, 2023
Table 41: Select Recombinant Protein Therapeutics in Phase 3 Clinical Trials, 2023
Table 42: Recombinant Protein Therapeutics in Phase 1 and 2 Clinical Trials, 2023
Table 43: Recombinant Protein Therapeutics in Phase 4 and Observational Clinical Trials, 2023
Table 44: Select Active Patents of Key Companies, 2020-2023
Table 45: ESG Rankings for Major Recombinant Protein Drug Companies, 2023*
Table 46: ESG: Environmental Overview
Table 47: ESG: Social Factors Overview
Table 48: ESG: Governance Overview
Table 49: Report Sources
Table 50: Glossary of Terms Used in the Recombinant Proteins Market
Table 51: Amgen Inc.: Company Snapshot
Table 52: Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 53: Amgen Inc.: Product Portfolio
Table 54: Amgen Inc.: News/Key Developments, 2022 and 2023
Table 55: Bayer AG: Company Snapshot
Table 56: Bayer AG: Financial Performance, FY 2022 and 2023
Table 57: Bayer AG: Product Portfolio
Table 58: Bayer AG: News/Key Developments, 2023
Table 59: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 60: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 61: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 62: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
Table 63: Lilly: Company Snapshot
Table 64: Lilly: Financial Performance, FY 2022 and 2023
Table 65: Lilly: Product Portfolio
Table 66: Lilly: News/Key Developments, 2023
Table 67: Merck KGaA: Company Snapshot
Table 68: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 69: Merck KGaA: Product Portfolio
Table 70: Merck KGaA: News/Key Developments, 2022 and 2023
Table 71: Novo Nordisk A/S: Company Snapshot
Table 72: Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
Table 73: Novo Nordisk A/S: Product Portfolio
Table 74: Novo Nordisk A/S: News/Key Developments, 2023 and 2024
Table 75: Pfizer Inc.: Company Snapshot
Table 76: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 77: Pfizer Inc.: Product Portfolio
Table 78: Pfizer Inc.: News/Key Developments, 2023
Table 79: Sandoz Group AG: Company Snapshot
Table 80: Sandoz Group AG: Financial Performance, FY 2022 and 2023
Table 81: Sandoz Group AG: Product Portfolio
Table 82: Sandoz Group AG: News/Key Developments, 2023
Table 83: Sanofi: Company Snapshot
Table 84: Sanofi: Financial Performance, FY 2022 and 2023
Table 85: Sanofi: Product Portfolio
Table 86: Sanofi: News/Key Developments, 2022-2024
Table 87: Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 88: Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 89: Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 90: Takeda Pharmaceutical Co. Ltd.: Key Developments, 2022 and 2023
List of Figures
Summary Figure: Global Market Shares of Recombinant Proteins, by Region, 2023
Figure 1: Basic Steps Involved in Recombinant Protein Production
Figure 2: Market Dynamics of Recombinant Proteins
Figure 3: Global Biopharmaceutical R&D Expenditures, 2020-2026
Figure 4: Applications of Recombinant Antibodies
Figure 5: Advantages and Disadvantages of Continuous Manufacturing
Figure 6: Global Market Shares of Recombinant Proteins, by Product Type, 2023
Figure 7: Global Market for Recombinant Hormone Proteins, 2021-2029
Figure 8: Global Market for Recombinant Hormone Proteins, by Region, 2021-2029
Figure 9: Global Market for Recombinant Cytokine Proteins, 2021-2029
Figure 10: Global Market for Recombinant Cytokine Proteins, by Region, 2021-2029
Figure 11: Global Market for Recombinant Enzyme Proteins, 2021-2029
Figure 12: Global Market for Recombinant Enzyme Proteins, by Region, 2021-2029
Figure 13: Advantages of Recombinant Antibodies
Figure 14: Global Market for Recombinant Antibody Proteins, 2021-2029
Figure 15: Global Market for Recombinant Antibody Proteins, by Region, 2021-2029
Figure 16: Global Market for Recombinant Antigen Proteins, 2021-2029
Figure 17: Global Market for Recombinant Antigen Proteins, by Region, 2021-2029
Figure 18: Global Market for Other Recombinant Proteins, 2021-2029
Figure 19: Global Market for Other Recombinant Proteins, by Region, 2021-2029
Figure 20: Global Market Shares of Recombinant Proteins, by Host Cell Type, 2023
Figure 21: Global Market for Recombinant Proteins from Bacterial Host Cells, 2021-2029
Figure 22: Global Market for Recombinant Proteins from Yeast and Fungi Host Cells, 2021-2029
Figure 23: Global Market for Recombinant Proteins from Mammalian Host Cells, 2021-2029
Figure 24: Global Market for Recombinant Proteins from Insect Host Cells, 2021-2029
Figure 25: Global Market for Recombinant Proteins from Other Host Cells, 2021-2029
Figure 26: Global Market Shares of Recombinant Proteins, by Application, 2023
Figure 27: Global Market for Recombinant Proteins for Therapeutic and Vaccine Applications, 2021-2029
Figure 28: Global Market for Recombinant Proteins for Therapeutic and Vaccine Applications, by Region, 2021-2029
Figure 29: Global Market for Recombinant Proteins for Biomedical Research, 2021-2029
Figure 30: Global Market for Recombinant Proteins for Biomedical Research, by Region, 2021-2029
Figure 31: Global Market for Recombinant Proteins for Diagnostics, 2021-2029
Figure 32: Global Market for Recombinant Proteins for Diagnostics, by Region, 2021-2029
Figure 33: Global Market for Recombinant Proteins, by Region, 2021-2029
Figure 34: North American Market Shares of Recombinant Proteins, by Country, 2023
Figure 35: European Market Shares of Recombinant Proteins, by Country, 2023
Figure 36: Asia-Pacific Market Shares of Recombinant Proteins, by Country, 2023
Figure 37: Key ESG Metrics of Recombinant Protein Companies
Figure 38: Amgen Inc.: Revenue Shares, by Product, FY 2023
Figure 39: Amgen Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 40: Bayer AG: Revenue Shares, by Business Unit, FY 2023
Figure 41: Bayer AG: Revenue Shares, by Country/Region, FY 2023
Figure 42: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 43: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 44: Lilly: Revenue Shares, by Business Unit, FY 2023
Figure 45: Lilly: Revenue Shares, by Country/Region, FY 2023
Figure 46: Merck KGaA: Revenue Shares, by Business Unit, FY 2023
Figure 47: Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 48: Novo Nordisk A/S: Revenue Shares, by Business Unit, FY 2023
Figure 49: Novo Nordisk A/S: Revenue Shares, by Country/Region, FY 2023
Figure 50: Pfizer Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51: Pfizer Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52: Sandoz Group AG: Revenue Shares, by Business Unit, FY 2023
Figure 53: Sandoz Group AG: Revenue Shares, by Country/Region, FY 2023
Figure 54: Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 55: Sanofi: Revenue Shares, by Country/ Region, FY 2023
Figure 56: Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 57: Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
